Emerald Innovations, Inc.
Boston, MA
- UEI
- MDE4D4W9J7H3
- CAGE
- 8AVC5
- Primary NAICS
- 541511 Custom Computer Programming Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 20 Park Plaza #322, Boston, MA 02116, USA
- Website
- emeraldinno.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The goal of this project is to develop an objective, quantitative, and user-friendly digital endpoint to assess… | Food and Drug Administration | $1,956,704 |
About Emerald Innovations, Inc.
Emerald Innovations, Inc. is a for-profit corporate entity registered to receive federal contract and grant awards from the U.S. government. It specializes in developing digital health technologies, including remote monitoring solutions and digital endpoints for clinical trials.
Emerald Innovations, Inc. was awarded a $1.96 million firm fixed price definitive contract by the Department of Health and Human Services' Food and Drug Administration to develop a quantitative, objective, and user-friendly digital endpoint to assess nocturnal scratching in children with atopic dermatitis. The endpoint aims to modernize product evaluation for atopic dermatitis treatments, as requested in the FDA's Fiscal Year 2023 Broad Agency Announcement for Advanced Research and Development of Regulatory Science. This contract has no set-aside and the work will be performed in Cambridge, Massachusetts over a thirty-month period ending in May 2026.
Through federal grant awards, Emerald Innovations, Inc. has developed remote monitoring solutions for COVID-19 patients as a sub-awardee to the University of Massachusetts Medical School. This project involved designing, developing, testing, and deploying an application to passively and continuously monitor the breathing, sleep, and mobility of COVID-19 patients quarantining at home. As a sub-awardee to Baylor College of Medicine, Emerald Innovations, Inc. was tasked with building an automated software pipeline for sensing and computing health metrics, a secure database for storing per-user health data, a user-friendly UI for navigating health metrics, and a system for continuous monitoring of sleep duration and sleep stages. This project involved deploying the system with 10 users for a one-month period and conducting user studies to evaluate usability and validate the produced metrics.
Quick answers
What is Emerald Innovations, Inc.'s UEI?
Emerald Innovations, Inc.'s Unique Entity ID (UEI) in SAM.gov is MDE4D4W9J7H3.
What is Emerald Innovations, Inc.'s CAGE code?
Emerald Innovations, Inc.'s CAGE code is 8AVC5.
What is Emerald Innovations, Inc.'s primary NAICS code?
Emerald Innovations, Inc.'s primary NAICS code is 541511 (Custom Computer Programming Services).
Where is Emerald Innovations, Inc. located?
Emerald Innovations, Inc.'s physical address in SAM.gov is 20 Park Plaza #322, Boston, MA 02116, USA.
Is Emerald Innovations, Inc. registered in SAM.gov?
Yes. Emerald Innovations, Inc.'s SAM.gov registration is active through September 28, 2027.
What is Emerald Innovations, Inc.'s most recent federal award?
Emerald Innovations, Inc.'s most recent federal contract award is The goal of this project is to develop an objective, quantitative, and user-friendly digital endpoint to assess… (75F40124C00013), from Food and Drug Administration, on December 6, 2023.
On GovTribe
See Emerald Innovations, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors